1st October 2018|News, Scientific Media Scientific success leads to strong portfolio of commercial deals for UK-based microbiome company, OptiBiotix Health
25th September 2018|Commercial Media, News OptiBiotix launches CHOLBIOME® cholesterol management range
11th September 2018|Investor Media, News U.S pharma deal signals major breakthrough for OptiBiotix probiotics range
23rd July 2018|Commercial Media, News OptiBiotix appoints Dr Sofia Kolyda as new Director of Research and Development
18th July 2018|Commercial Media, News SkinBioTherapeutics receives provisional ethics approval for human study
